CD4 and intrahepatic cholangiocarcinoma: With greater than 80% of cells dead by d16, the surviving T-cells, both CD4+ and CD8+, nonetheless continued to display Ag-specificity in ICC assays (10-40%, Figure 2A, 2B), but with scant evidence of proliferation from d9 forward (Figure 8B, 8D).